Drug Profile
Liothyronine sustained-release
Alternative Names: BCT-303; Liothyronine sodium; Sustained-release liothyronine sodium; Sustained-release T3; Thyromax; TriThroidLatest Information Update: 01 Oct 2021
Price :
$50
*
At a glance
- Originator ITL Pharma
- Developer IPE
- Class Amino acids; Small molecules; Thyronines
- Mechanism of Action Thyroid hormone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Hypothyroidism